TABLE 2.
Daptomycin susceptibility and mprF polymorphisms with β-lactam passage after 28 daysa
| Isolate | Passage | Replicate | DAP MIC (mg/liter) | β-lactam MIC (mg/liter)b | mprF SNP | MprF domain | div1b mutation | rpoB/C mutation |
|---|---|---|---|---|---|---|---|---|
| J01 | None | 0.5 | ||||||
| J03 | None | 2 | T345I | Bifunctional | rpoB S464P | |||
| Media | i | 2 | None | |||||
| Mediaa | ii | 1 | Y325H | Bifunctional | ||||
| Mediaa | iii | 1 | R437P | Synthase | ||||
| CROc | ii | 0.75 | 512 | V152G | Translocase | |||
| LOXc | ii | 0.125 | 32 | R788L | Synthase | Q425d | ||
| LOXc | iii | 0.125 | 32 | R788L | Synthase | Q415d | ||
| D592 | None | 0.5 | ||||||
| D712 | None | 2 | L341S | Bifunctional | ||||
| Media | i | 2 | None | |||||
| Media | ii | 1 | None | |||||
| Media | iii | 2 | None | |||||
| NAFe | iii | 1 | 256 | S337P | Bifunctional | |||
| CROe | i | 2 | 2,048 | M609T | Synthase | rpoC A567V | ||
| CROe | iii | 0.5 | 2,048 | G389A | Synthase | rpoB G767C | ||
| FOXe | ii | 0.5 | 512 | F657L | Synthase | |||
| LOXe | i | 0.5 | 1,024 | S136L | Translocase | |||
| LOXe | ii | 0.5 | 1,024 | S136L | Translocase | |||
| C24 | None | 0.5 | - | - | ||||
| C25 | None | 3–4 | S295L | Bifunctional | ||||
| Mediaf | i | 1 | S825d | Synthase | ||||
| Mediaf | ii | 1 | S825d | Synthase | ||||
| Media | iii | 2 | None | - | ||||
| FOXf | Iii | 1 | 64 | A315S | Bifunctional | |||
| LOXf | i | 0.125 | 8 | L84d | Translocase | A420E | ||
| LOXf | ii | 0.125 | 8 | L84d | Translocase | |||
| LOXf | iii | 0.125 | 8 | L84d | Translocase | E416d |
For the β-lactam-exposed strains, only the passages with additional mprF mutations (versus DAP-NS parent strain) are presented.
β-lactam MIC represents the MIC in the respective β-lactam after passage.
Passage isolates maintained MprF T345I and RpoB S464P.
Nonsense stop-gain mutation resulting in premature end of translation.
Passage isolates maintained MprF L341S.
Passage isolates maintained MprF S295L.